These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37257044)

  • 1. Impact of Human Papillomavirus Vaccine Against Anal Human Papillomavirus Infection, Anal Intraepithelial Neoplasia, and Recurrence of Anal Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
    Wei F; Alberts CJ; Albuquerque A; Clifford GM
    J Infect Dis; 2023 Nov; 228(11):1496-1504. PubMed ID: 37257044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
    Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
    N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S; De Vuyst H
    Curr Opin HIV AIDS; 2009 Jan; 4(1):57-63. PubMed ID: 19339940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.
    Mensah FA; Mehta MR; Lewis JS; Lockhart AC
    Oncologist; 2016 Apr; 21(4):453-60. PubMed ID: 26961923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype attribution and estimation of preventable fraction of anal intraepithelial neoplasia cases among HIV-infected men who have sex with men.
    Sahasrabuddhe VV; Castle PE; Follansbee S; Borgonovo S; Tokugawa D; Schwartz LM; Lorey TS; LaMere BJ; Gage JC; Fetterman B; Boyle S; Sadorra M; Tang SD; Darragh TM; Wentzensen N
    J Infect Dis; 2013 Feb; 207(3):392-401. PubMed ID: 23162133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Anal High-Grade Squamous Intraepithelial Lesions, and Prevention Through Human Papillomavirus Vaccination, in Young Men Who Have Sex With Men Living With Human Immunodeficiency Virus.
    Palefsky JM; Lensing SY; Belzer M; Lee J; Gaur AH; Mayer K; Futterman D; Stier EA; Paul ME; Chiao EY; Reirden D; Goldstone SE; Tirado M; Cachay ER; Barroso LF; Da Costa M; Darragh TM; Rudy BJ; Wilson CM; Kahn JA
    Clin Infect Dis; 2021 Oct; 73(8):1388-1396. PubMed ID: 33991185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
    Kelly H; Chikandiwa A; Alemany Vilches L; Palefsky JM; de Sanjose S; Mayaud P
    Lancet HIV; 2020 Apr; 7(4):e262-e278. PubMed ID: 32109408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
    Deshmukh AA; Chhatwal J; Chiao EY; Nyitray AG; Das P; Cantor SB
    Clin Infect Dis; 2015 Nov; 61(10):1527-35. PubMed ID: 26223993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.
    Wilkin TJ; Chen H; Cespedes MS; Leon-Cruz JT; Godfrey C; Chiao EY; Bastow B; Webster-Cyriaque J; Feng Q; Dragavon J; Coombs RW; Presti RM; Saah A; Cranston RD
    Clin Infect Dis; 2018 Oct; 67(9):1339-1346. PubMed ID: 29659751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults.
    Tong WW; Hillman RJ; Kelleher AD; Grulich AE; Carr A
    HIV Med; 2014 Feb; 15(2):65-76. PubMed ID: 24007498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.
    Deshmukh AA; Chiao EY; Das P; Cantor SB
    Vaccine; 2014 Dec; 32(51):6941-6947. PubMed ID: 25444820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anal human papillomavirus infection and anal HPV-related disorders in women: a systematic review.
    Stier EA; Sebring MC; Mendez AE; Ba FS; Trimble DD; Chiao EY
    Am J Obstet Gynecol; 2015 Sep; 213(3):278-309. PubMed ID: 25797230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Anal Cancer Following Benign Anal Disease and Anal Cancer Precursor Lesions: A Danish Nationwide Cohort Study.
    Faber MT; Frederiksen K; Palefsky JM; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):185-192. PubMed ID: 31597665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccination and anal high-grade precancerous lesions and cancer-a real-world effectiveness study.
    Baandrup L; Maltesen T; Dehlendorff C; Kjaer SK
    J Natl Cancer Inst; 2024 Feb; 116(2):283-287. PubMed ID: 37718496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
    Harder T; Wichmann O; Klug SJ; van der Sande MAB; Wiese-Posselt M
    BMC Med; 2018 Jul; 16(1):110. PubMed ID: 30016957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination.
    Ong JJ; Walker S; Grulich A; Hoy J; Read TRH; Bradshaw C; Chen M; Garland SM; Cornall A; Hillman R; Templeton DJ; Hocking J; Eu B; Tee BK; Chow EPF; Fairley CK
    Sex Transm Dis; 2019 Apr; 46(4):229-233. PubMed ID: 30870323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women.
    Heard I; Etienney I; Potard V; Poizot-Martin I; Moore C; Lesage AC; Ressiot E; Crenn-Hebert C; Fléjou JF; Cubie H; Costagliola D; Darragh TM;
    Clin Infect Dis; 2015 May; 60(10):1559-68. PubMed ID: 25645213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol.
    Stankiewicz Karita HC; Hauge K; Magaret A; Mao C; Schouten J; Grieco V; Xi LF; Galloway DA; Madeleine MM; Wald A
    JAMA Netw Open; 2019 Apr; 2(4):e190819. PubMed ID: 30977845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women.
    Hessol NA; Holly EA; Efird JT; Minkoff H; Schowalter K; Darragh TM; Burk RD; Strickler HD; Greenblatt RM; Palefsky JM
    AIDS; 2009 Jan; 23(1):59-70. PubMed ID: 19050387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial.
    Goldstone SE; Giuliano AR; Palefsky JM; Lazcano-Ponce E; Penny ME; Cabello RE; Moreira ED; Baraldi E; Jessen H; Ferenczy A; Kurman R; Ronnett BM; Stoler MH; Bautista O; Das R; Group T; Luxembourg A; Zhou HJ; Saah A
    Lancet Infect Dis; 2022 Mar; 22(3):413-425. PubMed ID: 34780705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.